Annual Congress of the European Association of Nuclear Medicine October 12 – 16, 2019 Barcelona, Spain.
Is to design personalised, super-selective therapies and to identify more precise means of monitoring response to treatment in routine The now well-established tracks M2M - Molecule to Man (basic and translational science) and Do.MoRe (radionuclide therapy and dosimetry) promise to promote high-qual...
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 46; pp. 1 - 953 |
|---|---|
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Oct2019 Supplement 1
|
| Acceso en línea: | Ver este registro en EBSCOhost |